Dr. Anesa Ahamad

  • MD
  • Radiation oncologist
  • Spoken languages English


Career Positions

Current position(s)

  • Radiation Oncologist, Aventura, FL

Past position(s)

  • Oncology Advisor to Minister of Health in a Developing Country
  • Cancer Center Chief Operating Officer
  • Oncology Center Medical Director
  • Radiotherapy Department Medical Director



  • The University of Manchester, M.Sc. Oncology, Manchester, UK
  • The University of the West Indies, Faculty of Medical Sciences, BSc. Natural Sciences, St Augustine, Trinidad


  • The Royal College of Radiologists, London and the Christie Hospital, Manchester, UK


  • The University of Texas M.D. Anderson Cancer Center, Houston, TX


Awards and honors

  • Dr. Ahamad has received more than 30 awards and recognitions for her distinction in scientific and clinical work.


  • Information Needs Expressed During Patient-Oriented Oncology Consultations: Quantity, Variation, and Barriers
  • Routine bladder cancer treatment dictates divergence from trial-derived regimens: Results of treatment at 44 radiotherapy centers
  • Definitive radiotherapy for a head and neck Merkel cell carcinoma and comprehensive nodal volumes: a case for using a computer-designed variable-thickness compensator to reduce risk and severity of mucositis
Expand Publications
View 1 more


Definitive Radiotherapy for Merkel Cell Carcinoma of Temple: Intensity Modulated Radiotherapy (IMRT), Matched Electron Fields (MEF) or .decimal Bolus Electron Conformal Therapy (BolusECT”)?

Anesa Ahamad, 2016, American Radium Society Annual Meeting

View Presentation

What do Patients Really Want to Know?

Anesa Ahamad, 2017, ASCO Annual Meeting

View Presentation

Personalized Versus Standardized Responses to Patient Queries: Implications for Physician Time and Provision of Information

Anesa Ahamad, 2017, ASTRO Annual Meeting

View Presentation

Chemoradiation of Altered Fractionation for T2NOMO Glottic Cancer

Anesa Ahamad, 2018, ASTRO Annual Meeting

View Presentation

Bladder Preservation Strategies in a Multicenter Community Setting Produces Outcomes Comparable to Prospective Radiation Therapy Oncology Group (RTOG) Protocols

Anesa Ahamad, 2016, ASTRO Annual Meeting

View Presentation

Stereotactic Body Radiotherapy (SBRT) for Bone Metastases from Prostate Cancer: Does concurrent systemic therapy (CST) or prior local treatment affect acute complications?

Anesa Ahamad, 2016, ACRO Annual Meeting

View Presentation

Utilization, Efficacy and Toxicity of Hypofractionation for T1/12 Glottic Cancer Outside of Academic Centers

Anesa Ahamad, 2017, ASTRO Annual Meeting

View Presentation

Patients Treated with Bladder Preserving Trimodality Chemoradiation Therapy Off-Trial are Different to Those on Trials: Are Trial Protocols Applicable?

Anesa Ahamad, 2017, ASCO Annual Meeting

View Presentation

Geographic and Temporal Patterns of Fractionation and Concurrent Chemoradiation for treatment for T2N0M0 Glottic Carcinoma

Ahamad, A, S Salenius, R Ross, R Selvaraj, and E Fernandez, 2020, ACRO Annual Meeting

View Presentation


A. Ahamad, S. Salenius, R. Ross, E. Fernandez, 2016, ASTRO

View Presentation


Anesa W. Ahamad, Sharon Salenius, Chaundre K. Cross, Ron R. Allison, Eduardo B. Fernandez, 2016, ACRO

View Presentation


Ron R. Allison, Sharon A. Salenius, Andrej Hnatov, Cynthia Ballenger, Anesa Ahamad, Constantine A. Mantz, Eduardo Fernandez, Steven E. Finkelstein, 2016, American Radium Society 100th Anniversary Meeting

View Presentation


Anesa Ahamad, Donald Weed, Darel Pruett, Daniel Saulpaugh, Eduardo Fernandez, 2016, American Radium Society’s 100th Anniversary Meeting

View Presentation
Expand Presentations
View 11 more